Scenesse Interactions
No drug interactions were found for Scenesse (afamelanotide). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Scenesse (afamelanotide) is in the drug class melanocortin receptor agonists. Scenesse (afamelanotide) is used for Prevention of Phototoxicity in Erythropoietic Protoporphyria.
More about Scenesse (afamelanotide)
- Scenesse consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: melanocortin receptor agonists
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Imcivree
Imcivree (setmelanotide) is a prescription medicine for chronic weight management of obesity caused ...
Vyleesi
Vyleesi (bremelanotide) is used to treat hypoactive (low) sexual desire disorder (HSDD) in women ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Setmelanotide
Setmelanotide systemic is used for weight loss (obesity/overweight)
Bremelanotide
Bremelanotide systemic is used for hypoactive sexual desire disorder
Afamelanotide
Afamelanotide systemic is used for prevention of phototoxicity in erythropoietic protoporphyria
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.